This funding will support the development of Matrix’s AI-powered diagnostic device, aimed at modernising gynecological examinations and procedures.

Matrix is developing a digitally enabled, AI-supported pelvic assessment and diagnosis tool. It is designed for self-application, allowing patients to control their examination experience. The device is positioned as a contemporary alternative to the traditional speculum. It is expected to enhance patient engagement with critical gynecological appointments and improve the speed of diagnosis.

The device enables patients to conduct their own digital examination and collect swab samples. Results are then provided through an app, with the patient acting as the carrier of their own clinical record. This facilitates long-term data collection and follow-up. The device also includes AI software designed to streamline clinical practice, aiming to enhance scheduling and diagnostic accuracy.

Stiliyana Minkovska, Founder and CEO of Matrix, said: “The grant will enable us to produce multiple prototypes for distribution to early adopters and users, such as OBGYNs, nurses, GPs, and specialists. Grants like this are crucial for FemTech innovators, giving a platform and voice for women to build products for women. Our five-year plan includes introducing Matrix to both private and public health sectors. Ultimately, we aim to make Matrix accessible in less developed countries where women lack basic healthcare services.”

According to studies, 30% of women experience severe reproductive health issues, yet less than half seek necessary help. Sexual and reproductive ill-health accounts for 33% of the global disease burden among women.

Luke Smoothy, Founder and Director of Get It Made, commented: “We’re delighted to support this project with our manufacturing services. It has the potential to save lives, improve patient outcomes, and empower females globally. The NHS needs innovation, and this grant will help Matrix to identify health issues more quickly and provide a more dignified alternative to traditional examinations.”

Dr. John Horton, Practice Director at NHS Park End Surgery in Hampstead, also sees significant potential in Matrix. He said: “This is an exciting opportunity to assess patients with dignity. I can see many applications for this, including rectal application for examining men with spinal injuries.”

The development of Matrix represents a significant step forward in gynecological healthcare, aiming to improve patient experiences and outcomes while addressing critical health issues.